CEO David Hallal shared with CNBC how ElevateBio is disrupting the industry by offering partners an integrated tech stack with end-to-end manufacturing through its genetic medicine foundry model. Watch his full interview at https://lnkd.in/eACRdDps.
ElevateBio
Biotechnology Research
Waltham, Massachusetts 34,215 followers
A cell and gene therapy company accelerating access to technologies and expertise to change the future of medicine.
About us
ElevateBio is a technology-driven company built to power transformative genetic medicines today and for many decades to come. The Company commercializes its enabling technologies, manufacturing capabilities, and industry-leading expertise through partnerships to accelerate development across a breadth of therapeutic approaches and modalities. The ElevateBio ecosystem combines multiple R&D technology platforms – including Life Edit, a next-generation, full-spectrum gene editing platform; comprehensive cell engineering technologies; and an expanded viral and non-viral therapeutic delivery platform – with BaseCamp®, its end-to-end genetic medicine cGMP manufacturing and process development business, to accelerate the discovery and development of advanced therapeutics. ElevateBio aims to be the dominant engine inside the world’s greatest scientific advancements harnessing human cells and genes to alter disease.
- Website
-
https://www.elevate.bio/
External link for ElevateBio
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Waltham, Massachusetts
- Type
- Privately Held
- Specialties
- cell therapy, gene therapy, and cell and gene therapy
Locations
-
Primary
200 Smith St
Waltham, Massachusetts 02451, US
Employees at ElevateBio
Updates
-
Discover how Life Edit Therapeutics is harnessing the power of Artificial Intelligence (AI) to advance protein discovery and engineering. Hear what Joel Parker and SHAORONG (Ron) CHONG, share what's happening inside the labs! Watch the full video below:
-
Michael Paglia, our Chief Technology Officer, is attending the 2024 Cell & Gene Meeting on the Mesa! Mike will speak on the panel “Top Five Regulatory and CMC Highlights to Advance the Field in 2024” on Wednesday, October 9 at 11 am. The annual Meeting on the Mesa brings together industry leaders who are working to advance cutting-edge research into cures. Learn more here: meetingonthemesa.com
-
Technological innovation is vital to the development and manufacturing of cell and gene therapies. At ElevateBio, we know the true potential of these complex therapeutics. Our visibility and access to a wide range of tools and technologies enable us to span the full spectrum of genetic medicine modalities. This broader perspective informs how we evaluate tools and technologies and apply them to the needs of CGTs. Discover how our Emerging Technology Lab focuses on new technologies benefiting genetic medicines:
-
From concept to commercialization– we’ll be your partner every step of the way. At BaseCamp, we have the state-of-the-art facilities, technologies, operations, processes, and manufacturing capabilities. No matter your genetic medicine needs, our team of experts is equipped to support you at any stage. Learn more here: https://lnkd.in/ebFYRujy. #BaseCamp #CultureOfExpedition
-
We'll be participating at the 2024 ISPE Product Show! Join Mario Miele, SVP, Facilities & Engineering, for the FOYA Panel discussion on Oct 2 at Gillette Stadium. Learn more here: https://lnkd.in/ezA-mMpj. See you there! #ISPEProductShow #ElevateBio
-
Our LentiPeak™ lentiviral vector (LVV) platform is customized to meet your specific development needs. We offer our partners speed, control strategies, and expertise - accelerating your timeline and reducing your manufacturing costs. Learn more here: https://lnkd.in/ed8fRD-F. #ElevateBio #LentiviralVectors
-
Reverse transcriptase (RT) editing involves cutting one DNA strand, then replacing an existing DNA sequence with a new sequence that is encoded by the guide RNA (gRNA). Our approach takes advantage of our panel of RNA-guided nucleases – coupled with our expertise in target screening, analysis, and optimization – to enable optimal editing of the target locus. Learn more about our editing modalities at https://lnkd.in/e8PRHJnj. #ReverseTranscriptaseEditing #GeneEditing
-
We'll be presenting at Cell & Gene Therapy International! Join Miranda Williams, Scientist II, Analytical Development, for the poster presentation "Analytical Capabilities at ElevateBio BaseCamp Utilizing LentiPeak™" at 10:30 AM on Sept 25. Learn more at: https://lnkd.in/d9nmdak #ElevateBio #CellAndGeneTherapy
-
Apheresis selectively removes and collects specific blood components, like white blood cells or plasma, for a therapeutic purpose. When it comes to apheresis, our experts ensure precise and compliant apheresis processes, providing tailored solutions to fit your therapeutic needs from development to production, supporting you through progression of your clinical trials. From site identification to training collection and support, we're here to guide you through seamless execution. Let’s partner to create innovative therapies. Learn more: https://lnkd.in/eUQd4x8p .